Indinavir-treated Cryptococcus neoformans promotes an efficient antifungal immune response in immunosuppressed hosts

Medical Mycology

Volumn 44, Issue 2, 2006, Pages 119-126

  Pericolini, Eva ^a   Cenci, Elio ^a   Monari, Claudia ^a   Perito, Stefano ^a   Mosci, Paolo ^a   Bistoni, Giovanni ^b   Vecchiarelli, Anna ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cryptococcus neoformans; Fungal virulence; Fungi; Immune response; Immunoregulation; Indinavir

Indexed keywords

CD14 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE; FC RECEPTOR; FUNGUS ANTIGEN; GAMMA INTERFERON; INDINAVIR; INTERLEUKIN 12; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ANTIGEN EXPRESSION; ARTICLE; BRAIN TISSUE; CELL SURVIVAL; COLONY FORMING UNIT; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG EXPOSURE; FEMALE; FUNGAL VIRULENCE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INOCULATION; LETHALITY; LIVER; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; SPLEEN CELL; T LYMPHOCYTE; TREATMENT OUTCOME; UPREGULATION;

ANIMALS; ANTIGENS, CD14; ANTIGENS, CD40; ANTIGENS, CD86; CD4-POSITIVE T-LYMPHOCYTES; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DENDRITIC CELLS; FEMALE; HIV PROTEASE INHIBITORS; IMMUNOCOMPROMISED HOST; INDINAVIR; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; NITRIC OXIDE; RECEPTORS, IGG;

ANIMALIA; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 31344449267     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780500252020     Document Type: Article

References (28)

1. Lim, TS, and Murphy, JW. (1980) Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice Infect Immun, 30, pp. 5-11.
2. Decken, K, and Kohler, G, and Palmer-Lehmann, K, and (1998) Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans Infect Immun, 66, pp. 4994-5000.
3. Kawakami, K, and Qifeng, X, and Tohyama, M, and Qureshi, MH, and Saito, A. (1996) Contribution of tumour necrosis factor-alpha (TNF-alpha) in host defence mechanism against Cryptococcus neoformans Clin Exp Immunol, 106, pp. 468-474.
4. Kawakami, K, and Qureshi, MH, and Zhang, T and (1997) IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production J Immunol, 159, pp. 5528-5534.
5. Kawakami, K, and Koguchi, Y, and Qureshi, MH and (2000) IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells J Immunol, 165, pp. 941-947.
6. Saag, MS, and Graybill, RJ, and Larsen, RA, and (2000) Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America Clin Infect Dis, 30, pp. 710-718.
7. Ho, DD, and Neumann, AU, and Perelson, AS, and (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature, 373, pp. 123-126.
8. Wei, X, and Ghosh, SK, and Taylor, ME, and (1995) Viral dynamics in human immunodeficiency virus type 1 infection Nature, 373, pp. 117-122.
9. Notermans, DW, and van Leeuwen, R, and Lange, JM. (1996) Treatment of HIV infection. Tolerability of commonly used antiretroviral agents Drug Saf, 15, pp. 176-187.
10. Merry, C, and Barry, MG, and Mulcahy, F, and Halifax, KL, and Back, DJ. (1997) Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients Aids, 11, pp. F117-120.
11. Foudraine, NA, and Weverling, GJ, and van Gool, T, and (1998) Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy Aids, 12, pp. 35-41.
12. Zingman, BS. (1996) Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir N Engl J Med, 334, pp. 1674-1675.
13. Ives, NJ, and Gazzard, BG, and Easterbrook, PJ. (2001) The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic J Infect, 42, pp. 134-139.
14. Monari, C, and Pericolini, E, and Bistoni, G, and (2005) Influence of indinavir on virulence and growth of Cryptococcus neoformans J Infect Dis, 191, pp. 307-311.
15. Flesch, IE, and Kaufmann, SH. (1991) Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: Role of reactive nitrogen intermediates Infect Immun, 59, pp. 3213-3218.
16. Huffnagle GB, Lipscomb MF. Cells and cytokines in pulmonary cryptococcosis. Res Immunol 1998; 149: 387-396, discussion 512-514.
17. Vecchiarelli, A, and Pietrella, D, and Dottorini, M, and (1994) Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages Clin Exp Immunol, 98, pp. 217-223.
18. Banchereau, J, and Steinman, RM. (1998) Dendritic cells and the control of immunity Nature, 392, pp. 245-252.
19. van Kooyk, Y, and Geijtenbeek, TB. (2003) DC-SIGN: Escape mechanism for pathogens Nat Rev Immunol, 3, pp. 697-709.
20. Shortman, K, and Liu, YJ. (2002) Mouse and human dendritic cell subtypes Nat Rev Immunol, 2, pp. 151-161.
21. Palucka, K, and Banchereau, J. (2002) How dendritic cells and microbes interact to elicit or subvert protective immune responses Curr Opin Immunol, 14, pp. 420-431.
22. Retini, C, and Kozel, TR, and Pietrella, D, and (2001) Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans Infect Immun, 69, pp. 6064-6073.
23. de Waal Malefyt, R, and Yssel, H, and Roncarolo, MG, and Spits, H, and de Vries, JE. (1992) Interleukin-10 Curr Opin Immunol, 4, pp. 314-320.
24. Maldonado-Lopez, R, and De Smedt, T, and Michel, P, and (1999) CD8alpha+ and CD8alpha - subclasses of dendritic cells direct the development of distinct T helper cells in vivo J Exp Med, 189, pp. 587-592.
25. Pulendran, B, and Smith, JL, and Caspary, G, and (1999) Distinct dendritic cell subsets differentially regulate the class of immune response in vivo Proc Natl Acad Sci USA, 96, pp. 1036-1041.
26. Steinman, RM, and Nussenzweig, MC. (2002) Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance Proc Natl Acad Sci USA, 99, pp. 351-358.
27. Vecchiarelli, A, and Pietrella, D, and Lupo, P, and (2003) The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation J Leukoc Biol, 74, pp. 370-378.
28. Manfredi, R, and Calza, L, and Chiodo, F. (2003) AIDS-associated Cryptococcus infection before and after the highly active antiretroviral therapy era: Emerging management problems Int J Antimicrob Agents, 22, pp. 449-452.